IPI Leads Nation in Local Cancer Drug Production

IPI Leads Nation in Local Cancer Drug Production


For the first time in Iraq, a locally produced cancer drug is being supplied to health institutions, marking a significant milestone in the nation's pharmaceutical industry. Under the guidance of Minister of Health, Dr. Saleh Al-Hasnawi, the Ministry of Health has initiated robust cooperation with Iraqi factories to bolster local production of essential medicines.

The Iraqi pharmaceutical factory in New Baghdad, established in 1954 and inaugurated by the late King Faisal II, spans approximately 5,000 square meters and produces over 70 types of medical materials. Following a comprehensive development program initiated in 2011, the factory now adheres to the latest European Global Good Manufacturing standards.

Over the past 90 days, 157 contracts have been signed between the general pharmaceutical company and national factories. This collaboration aims to ensure pharmaceutical safety and self-sufficiency in medicine production. The factory's recent achievements include the production of cancer drugs and thalassemia medicine, with substantial cost reductions of up to 60% compared to foreign suppliers.

The factory has also secured a contract with the Ministry of Health to produce 20 million diabetes pills, demonstrating its capacity to meet the country's health needs. With ongoing government support, the factory is poised to export cancer drugs internationally, having produced quantities exceeding the Ministry of Health's requirements.

This strategic move not only supports local industry but also ensures that high-quality, affordable medicines are accessible to Iraqi patients, reinforcing Iraq's commitment to self-reliance in healthcare.